Both operating divisions... )--Protalex, Inc. , a clinical-stage biopharmaceutical company, today announced dosing of the first patient in its European Phase Ib study of PRTX-100 ... )--The Board of Directors of the Alzheimer's Association, California Southland Chapter announced today its decision to separate from the national Alzheimer's Association,... Tel-Instrument Electronics Corp. Announces Third Quarter Revenues of $6.1 Million and Receipt of $1.43 Million CRAFT 708 Order )--Tel-Instrument Electronics Corp. today announced that FY 2016 third quarter unaudited revenues for the period ending... The Phoenix Companies, Inc. Announces Consent Solicitation Relating to 7.45% Quarterly Interest Bonds Due 2032 in Connection with Proposed Acquisition by Nassau )--Phoenix Cos.